New trial into COVID-19 vaccine response in lymphoid cancer patients
A scientist based at the Centre for Cancer Immunology is leading a new observational trial, evaluating immune responses in patients with lymphoid cancers to COVID-19 vaccines.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
